Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Irritable Bowel Syndrome, August 2025 Free Subscription Abstracts Retrieve all available abstracts of the following 97 articles: HTML format

Single Articles

1. ZHOU Y, Zhou B, Ke X, Ma Y, et al
   Glucokinase activators contribute to gastrointestinal disease risks through metabolic-immune interplay in the gut-liver axis: insights from a multi-omics study.
   Acta Diabetol. 2025 Aug 1. doi: 10.1007/s00592-025-02571.
   PubMed    
   Abstract available
   
   

2. WU H, Zhao F, Jia W, Li P, et al
   [L'axe cerveau-intestin : l'aube des troubles neurologiques ?].
   Ann Biol Clin (Paris). 2025;83:0.
   PubMed    
   Abstract available
   
   

3. LENOVER MOYER MB, Shenk MK
   Physical Activity and Irritable Bowel Syndrome: The Role of Evolutionary Mismatch in Chronic Disease Risk.
   Am J Biol Anthropol. 2025;187:e70104.
   PubMed    
   Abstract available
   
   

4. KUHNELOVA S, Roznovsky L, Dolezilkova J, Madar R, et al
   Blastocystis in the human gastrointestinal tract - commensal or "silent" pathogen?
   Epidemiol Mikrobiol Imunol. 2025;74:118-125.
   PubMed    
   Abstract available
   
   

5. JACOBS JP, Labus JS, Dong TS, Shin AS, et al
   Extraintestinal symptoms in irritable bowel syndrome are associated with stress reactivity and the gut microbiome in a sex-dependent manner.
   Clin Gastroenterol Hepatol. 2025 Jul 29:S1542-3565(25)00640.
   PubMed    
   
   
   

6. WU Y, Guo F, Xu X, Liu Y, et al
   Based on Proteomics Data Revealing the Potential of Traditional Chinese Medicine in Treating Irritable Bowel Syndrome.
   Mediators Inflamm. 2025;2025:7748351.
   PubMed    
   Abstract available
   
   

7. POULADI A, Arabpour E, Bahrami O, Sadeghi A, et al
   Impacts of the Long-Term Low-FODMAP Diet in Patients With Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
   J Hum Nutr Diet. 2025;38:e70105.
   PubMed    
   Abstract available
   
   

8. SHABBIR P, Malik S, Naveed M, Anwar MF, et al
   Remission of irritable bowel syndrome with lifestyle medicine.
   Pak J Med Sci. 2025;41:2156-2159.
   PubMed    
   Abstract available
   
   

9. SAEEDINIA E, Poursharifi H, Momeni F, Vahedi M, et al
   Psychological determinants of irritable bowel syndrome and its impact on quality of life: a machine learning approaches.
   Gastroenterol Hepatol Bed Bench. 2025;18:100-114.
   PubMed    
   Abstract available
   
   

10. AYDEMIR S, Arvas YE, Aydemir ME, Barlik F, et al
    Antiprotozoal Effects of Pediococcus acidilactici-Derived Postbiotic on Blastocystis Subtypes ST1/ST3.
    Pathogens. 2025;14:664.
    PubMed    
    Abstract available
    
    

11. DUZEN OFLAS N, Yilmaz Urun Y
    Vitamin D Deficiency and Supplementation in Irritable Bowel Syndrome: Retrospective Evaluation of Subtype and Sex-Based Differences.
    Medicina (Kaunas). 2025;61:1229.
    PubMed    
    Abstract available
    
    

12. SAVULESCU-FIEDLER I, Benea SN, Caruntu C, Nancoff AS, et al
    Rewiring the Brain Through the Gut: Insights into Microbiota-Nervous System Interactions.
    Curr Issues Mol Biol. 2025;47:489.
    PubMed    
    Abstract available
    
    

13. CHIMINACIO I, Petry JF, Campos NNLRV, Obrzut C, et al
    Multiple lesions of endometriosis in the small intestine treated by the shaving technique: A case report.
    Case Rep Womens Health. 2025;47:e00731.
    PubMed    
    Abstract available
    
    

14. CHEN A, Shi J, Wu H, Shi W, et al
    Chronic back pain: recognising twelfth rib syndrome.
    BMJ Case Rep. 2025;18:e266106.
    PubMed    
    Abstract available
    
    

15. NAIZR S, Abbas Z, Gazder DP, Shahid A, et al
    Incidence and Characterization of SIBO in NAFLD Patients.
    Euroasian J Hepatogastroenterol. 2025;15:38-43.
    PubMed    
    Abstract available
    
    

16. ALHOSANI N, Al Rifai A
    Pancreatic Heterotopia Presenting as Ileal Intussusception in an Adult: A Case Report and Literature Review.
    Cureus. 2025;17:e86745.
    PubMed    
    Abstract available
    
    

17. HANNING N, Verboven R, Smet A, Timmermans JP, et al
    In-depth study of gastrointestinal motility, intestinal barrier function and secretory function in an irritable bowel syndrome post-inflammatory rat model.
    Eur J Pharmacol. 2025;1004:177990.
    PubMed    
    Abstract available
    
    

18. MONIRUZZAMAN M, Shah A, Morrison M, Koloski N, et al
    Mechanisms of action and clinical effectiveness of herbal treatments for disorders of gut-brain interaction.
    Dig Liver Dis. 2025 Jul 25:S1590-8658(25)00905-3. doi: 10.1016/j.dld.2025.
    PubMed    
    Abstract available
    
    

19. FLEMING C, Hardacre CJ, Memon A
    Pneumatosis intestinalis presenting with acute abdomen.
    BMJ Case Rep. 2025;18:e264888.
    PubMed    
    Abstract available
    
    

20. KUZMINSKA O, Vitkovska B, Kuvaiskov Y, Hatton CG, et al
    Efficacy and Safety of the Enterosorbent Silicolgel in Irritable Bowel Syndrome, IBS-D and IBS-M: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial.
    Neurogastroenterol Motil. 2025 Jul 25:e70118. doi: 10.1111/nmo.70118.
    PubMed    
    Abstract available
    
    

21. ZHOU Y, Zhang L, Xia T, Zhang X, et al
    Effects of manual acupuncture on fatty acid metabolism in a rat model of diarrhea-predominant irritable bowel syndrome: a multi-tissue metabolomic and plasma lipidomic investigation.
    Acupunct Med. 2025;43:218-232.
    PubMed    
    Abstract available
    
    

22. DEKIMECHE I, Grasland M, Jolu A, Essid D, et al
    Iconographic validation of the Bristol scale in patient with neurological diseases.
    Fr J Urol. 2025 Aug 5:102949. doi: 10.1016/j.fjurol.2025.102949.
    PubMed    
    Abstract available
    
    

23. VALITUTTI F, Cavalli E, Leter B, Leonard M, et al
    Coeliac disease and microbiota: is it time for personalised biotics intervention? A scoping review.
    BMJ Nutr Prev Health. 2025;8:e001100.
    PubMed    
    Abstract available
    
    

24. CHIN SW, Low ZY, Tan WQ, Azman AS, et al
    Microbiota-Host Interactions: Exploring Their Dynamics and Contributions to Human Diseases.
    Microbiologyopen. 2025;14:e70043.
    PubMed    
    Abstract available
    
    

25. SILVA MT, Amado DM, Rocha PRS, Barreto JOM, et al
    Integrative and Complementary Health Practices for Chronic Pain: summary of clinical guideline recommendations.
    Epidemiol Serv Saude. 2025;34:e20240771.
    PubMed    
    Abstract available
    
    

26. FOWLER S, Paech GM, Hoedt EC, Pryor JC, et al
    Altered peripheral CRY1 gene expression may contribute to both organic and functional gastrointestinal disease.
    Exp Physiol. 2025 Aug 6. doi: 10.1113/EP092725.
    PubMed    
    Abstract available
    
    

27. HAN LL, Mei CF, Xue H
    Exploring the relationship between co-abundance of gut microbiota and novel metabolic pathways in different subtypes of irritable bowel syndrome: insights from the American Gut Project.
    Front Med (Lausanne). 2025;12:1615717.
    PubMed    
    Abstract available
    
    

28. CHEN SJ, Chang HC, Gau SY
    Psoriasis Patients are Associated with Increased Risk of New-Onset Irritable Bowel Syndrome: A Multicenter, Retrospective Cohort Study.
    Int J Med Sci. 2025;22:3422-3428.
    PubMed    
    Abstract available
    
    

29. VILLE A, McRae R, Nomchong J, Reidlinger DP, et al
    Effects of a Low FODMAP Diet in Inflammatory Bowel Disease and Patient Experiences: A Mixed Methods Systematic Literature Review and Meta-Analysis.
    J Hum Nutr Diet. 2025;38:e70106.
    PubMed    
    Abstract available
    
    

30. WEI Z, Zhang Y, Xu S, Tong M, et al
    Paternal separation as an independent risk factor for irritable bowel syndrome in rural Chinese left-behind children: a multicenter cross-sectional study.
    Front Public Health. 2025;13:1592358.
    PubMed    
    Abstract available
    
    

31. AGUILERA-LIZARRAGA J, Hussein H, Cuende-Estevez M, Boeckxstaens G, et al
    Response to Rossi et al.
    Neurogastroenterol Motil. 2025 Aug 4:e70134. doi: 10.1111/nmo.70134.
    PubMed    
    
    
    

32. KOLOSKI NA, Jones MP, Shah A, Holtmann G, et al
    Evidence for Brain-To-Gut and Gut-To-Brain Pathways in Primary Care Patients With Disorders of Gut-Brain Interaction, Inflammatory Bowel Disease and Gastroesophageal Reflux Disease.
    Neurogastroenterol Motil. 2025 Aug 4:e70117. doi: 10.1111/nmo.70117.
    PubMed    
    Abstract available
    
    

33. LEE TY, Lin YH, Chang WY, Lin LY, et al
    5-HT(7) antagonists confer analgesia via suppression of neurotrophin overproduction in submucosal nerves of mouse models with visceral hypersensitivity.
    J Physiol. 2025 Aug 4. doi: 10.1113/JP286444.
    PubMed    
    Abstract available
    
    

34. ZHAO D, Zhou G, Shen Z, Hong Y, et al
    Capsaicin ameliorates irritable bowel syndrome in a mouse model by restoring intestinal barrier function and promoting gut microbial homeostasis.
    Chin Med J (Engl). 2025 Aug 4. doi: 10.1097/CM9.0000000000003750.
    PubMed    
    
    
    

35. OZOJIDE KO, Ozigbo AA, Ghartey KK, Okobi OE, et al
    Demographic and Clinical Epidemiology of Irritable Bowel Syndrome in U.S. Community Health Centers: A Cross-Sectional Analysis of the 2022-2023 National Ambulatory Medical Care Survey.
    Cureus. 2025;17:e87124.
    PubMed    
    Abstract available
    
    

36. YUAN R, Zhou Y, Ren Y, Hou X, et al
    Mendelian Randomization Analysis Reveals Causal Associations Between Beverages and Irritable Bowel Syndrome: Alcohol, but Not Others.
    Food Sci Nutr. 2025;13:e70761.
    PubMed    
    Abstract available
    
    

37. ISHIHARA N, Kimura S, Hase K
    [An Intestinal Metabolite Exacerbates Stress-induced Diarrhea].
    Yakugaku Zasshi. 2025;145:667-672.
    PubMed    
    Abstract available
    
    

38. EL-SALHY M, Valeur J, Bronstad I, Gilja OH, et al
    Possible Role of Butyric Acid in Long-Term Symptom Relief in Irritable Bowel Syndrome Patients Following Fecal Microbiota Transplantation.
    Neurogastroenterol Motil. 2025 Aug 1:e70115. doi: 10.1111/nmo.70115.
    PubMed    
    Abstract available
    
    

39. PALSSON O, Simren M, Sperber AD, Bangdiwala S, et al
    The Prevalence and Burden of Disorders of Gut-Brain Interaction (DGBI) before versus after the COVID-19 Pandemic.
    Clin Gastroenterol Hepatol. 2025 Jul 23:S1542-3565(25)00623.
    PubMed    
    Abstract available
    
    

40. HUGHES M, Ruaro B, McMahan ZH, Alam U, et al
    Raynaud's phenomenon is associated with an increased risk of cardiovascular disease and venous thromboembolism.
    Semin Arthritis Rheum. 2025;74:152799.
    PubMed    
    Abstract available
    
    

41. SCHARF MW, Forsgard RA, Prado SBR, Ganda Mall JP, et al
    Acute effects of butyrate on intestinal permeability in patients with irritable bowel syndrome assessed by a novel colonoscopy research model.
    Gut Microbes. 2025;17:2545414.
    PubMed    
    Abstract available
    
    

42. MAYINDZA EKAGHBA EL, Perruchon O, Lerouge P, Mengome LE, et al
    Effects of Polysaccharides Extracted from Stem Barks on the Spontaneous Contractile Activity of the Ileal Smooth Muscle.
    Molecules. 2025;30:3156.
    PubMed    
    Abstract available
    
    

43. MCCLAIN J, Capo G, Terris M, Santamaria P, et al
    Prevalence and Phenotype of Lower Urinary Tract Symptoms in Fibromyalgia: A Retrospective Observational Study at a Single Tertiary Medical Center.
    J Clin Med. 2025;14:5584.
    PubMed    
    Abstract available
    
    

44. SIRAGUSA N, Baldassari G, Ferrario L, Passera L, et al
    The Ten Dietary Commandments for Patients with Irritable Bowel Syndrome: A Narrative Review with Pragmatic Indications.
    Nutrients. 2025;17:2496.
    PubMed    
    Abstract available
    
    

45. ZHOU Q, Verne GN
    Molecular Mechanisms and Pathways in Visceral Pain.
    Cells. 2025;14:1146.
    PubMed    
    Abstract available
    
    

46. STONE J, Coebergh J, Khoja L, Butler M, et al
    Migraine and functional neurological disorder (FND)-a review of comorbidity and potential overlap.
    Brain Commun. 2025;7:fcaf288.
    PubMed    
    Abstract available
    
    

47. JUNG EH, Zheng W, Weiss RJ, Mathew NE, et al
    Colopathy associated with pentosan polysulfate use.
    Front Pharmacol. 2025;16:1494467.
    PubMed    
    Abstract available
    
    

48. ZHOU Y, Yang Z, Liu S, Xie S, et al
    Long-term risk of irritable bowel syndrome associated with MASLD, MASLD type and different cardiometabolic risk factors: a large-scale prospective cohort study.
    BMC Gastroenterol. 2025;25:576.
    PubMed    
    Abstract available
    
    

49. KILPATRICK LA, Chang L, Labus JS, Shin AS, et al
    Sex-based associations between neighborhood disadvantage and brain-gut alterations in individuals with irritable bowel syndrome.
    Biol Sex Differ. 2025;16:61.
    PubMed    
    Abstract available
    
    

50. ZHENG B, Huang Z, Wang Z, Du J, et al
    Association of dietary creatine intake from meat protein sources with different types of intestinal problems: insights from NHANES 2005-2010.
    Front Nutr. 2025;12:1586569.
    PubMed    
    Abstract available
    
    

51. SABOUR S, Sadeghi Koupaei H, Ghasemi H, Amin M, et al
    Anaerobic gut bacteria and their potential role in the initiation, exacerbation, and development of human colorectal cancer: a narrative review.
    Front Cell Infect Microbiol. 2025;15:1559001.
    PubMed    
    Abstract available
    
    

52. GONZALEZ LUNA AJ, Covarrubias Robles U, Castrejon Cardona CD, Cuevas Calla CV, et al
    Contained Perforation of a Jejunal Diverticulum in an Elderly Patient: A Case Report.
    Cureus. 2025;17:e87719.
    PubMed    
    Abstract available
    
    

53. IACOB T, Scarlata GGM, Abenavoli L, Leucuta DC, et al
    Irritable bowel syndrome after Clostridioides difficile infection.
    Med Pharm Rep. 2025;98:320-324.
    PubMed    
    Abstract available
    
    

54. HOLTMANN G, Talley NJ, Nandurkar S, Gibson PR, et al
    Randomized, Placebo-Controlled, Double-Blind 8-Week Trial on the Efficacy of A Proprietary Kiwifruit Extract on Constipation-Predominant Irritable Bowel Syndrome.
    JGH Open. 2025;9:e70250.
    PubMed    
    Abstract available
    
    

55. ARONIADIS OC, Guthmueller B, Dehlin K, Srivastava S, et al
    Safety and Efficacy of Fecal Microbiota, Live-jslm to Prevent Recurrent Clostridioides difficile Infection in Participants With Irritable Bowel Syndrome.
    Infect Dis Ther. 2025 Aug 10. doi: 10.1007/s40121-025-01208.
    PubMed    
    Abstract available
    
    

56. STEEN OD, Bos M, van Ockenburg SL, Zhou Y, et al
    Functional and internalizing disorders co-aggregate with cardiometabolic and immune-related diseases within families: a population-based cohort study.
    BMC Med. 2025;23:469.
    PubMed    
    Abstract available
    
    

57. THUEN C, Hinderaker HK, Steinsvik EK, Vikoren LAS, et al
    Implementing a digital treatment program for patients with irritable bowel syndrome into routine care: a qualitative evaluation of barriers and facilitators perceived by key stakeholders.
    BMC Health Serv Res. 2025;25:1049.
    PubMed    
    Abstract available
    
    

58. LILIEQUIST BE, Ljotsson B, Olafsdottir E, Braunschweig F, et al
    Symptom Preoccupation in Atrial Fibrillation and its Association With Quality of Life: A Cross-Sectional Study.
    JACC Adv. 2025;4:102058.
    PubMed    
    Abstract available
    
    

59. YIN J
    Transcutaneous Vagal Nerve Stimulation for Gastrointestinal Disorders.
    J Transl Gastroenterol. 2025;3:93-99.
    PubMed    
    Abstract available
    
    

60. WANG T, Song XG, Ruan JR, Han XY, et al
    [Study on the mechanism of moxibustion in improving autophagy of intestinal epithelial cells in rats with diarrhea-predominant irritable bowel syndrome based on PI3K/AKT/mTOR signaling pathway].
    Zhen Ci Yan Jiu. 2025;50:936-945.
    PubMed    
    Abstract available
    
    

61. ALZAMORA-SCHMATZ MC, Gubbels A
    More than the Lesion: Unraveling the Complexities of Endometriosis-Associated Pain.
    Semin Reprod Med. 2025 Aug 25. doi: 10.1055/s-0045-1811206.
    PubMed    
    Abstract available
    
    

62. JEONG YD, Kim S, Son Y, Kim TH, et al
    Global Prevalence of Functional Abdominal Pain Disorder among Children and Adolescents According to the Rome III and IV Criteria: A Systematic Review and Meta-Analysis.
    Gut Liver. 2025 Aug 25. doi: 10.5009/gnl250225.
    PubMed    
    Abstract available
    
    

63. GHOSH D, Mittal A, Arora MK
    Effect of Source and Degree of Esterification of High Methoxyl Pectin on Oral Colon-Targeted Multiparticulated Delivery of Otilonium Bromide.
    ACS Omega. 2025;10:36481-36495.
    PubMed    
    Abstract available
    
    

64. BUREYCHAK T, Sjodahl J, Barazanji N, Orell G, et al
    Exploring Associations of Different Types of Childhood Trauma With Symptomatology in Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2025 Aug 24:e70148. doi: 10.1111/nmo.70148.
    PubMed    
    Abstract available
    
    

65. MADVA EN, Huffman JC, Castillo C, Harnedy LE, et al
    A Randomized Waitlist-Controlled Trial of a Positive Psychology Intervention for Irritable Bowel Syndrome: The WISH Proof-of-Concept Trial.
    Neurogastroenterol Motil. 2025 Aug 24:e70146. doi: 10.1111/nmo.70146.
    PubMed    
    Abstract available
    
    

66. ZHANG Q, He M, Wang X, Gao J, et al
    Integrating gene expression, neurochemical signatures, and neurocognitive profiles to decode cortical reorganization in IBS-D.
    Prog Neuropsychopharmacol Biol Psychiatry. 2025 Aug 22:111474.
    PubMed    
    Abstract available
    
    

67. MEHRA A, Sachdeva V, Khanna J, Singh G, et al
    Mirtazapine revisited: new therapeutic perspectives and formulation advances.
    Naunyn Schmiedebergs Arch Pharmacol. 2025.
    PubMed    
    Abstract available
    
    

68. MELCHIOR C, Hammer H, Bor S, Orozco EB, et al
    European Consensus on Functional Bloating and Abdominal Distension-An ESNM/UEG Recommendations for Clinical Management.
    United European Gastroenterol J. 2025 Aug 22. doi: 10.1002/ueg2.70098.
    PubMed    
    Abstract available
    
    

69. FAN X, Li Y, Lin X
    A pharmacovigilance study of the association between linaclotide/plecanatide and muscle spasms based on food and drug administration adverse event reporting system.
    Front Pharmacol. 2025;16:1635792.
    PubMed    
    Abstract available
    
    

70. FAZELI MOGHADAM E, Samadi M, Mohammadi S, Yarizadeh H, et al
    The Relationship of Dietary Nutrient Patterns and Irritable Bowel Syndrome: A Multicenter Case-Control Study.
    Food Sci Nutr. 2025;13:e70742.
    PubMed    
    Abstract available
    
    

71. TSENG S, Pathria M
    Mastocytic enterocolitis in a patient with chronic diarrhoea.
    BMJ Case Rep. 2025;18:e266244.
    PubMed    
    Abstract available
    
    

72. HASENBRING M, Levenig C, Titze C
    [Comorbidity of chronic pain and fatigue : Common mechanisms, common treatment steps?].
    Schmerz. 2025 Aug 21. doi: 10.1007/s00482-025-00898.
    PubMed    
    Abstract available
    
    

73. XU JG, Yuan Y, Ma HK, Huang S, et al
    Electroacupuncture ameliorates visceral hypersensitivity and negative emotions by regulating paraventricular hypothalamic nucleus and colonic corticotropin-releasing factor signaling.
    World J Psychiatry. 2025;15:107342.
    PubMed    
    Abstract available
    
    

74. CHEN X, Liu X, Li F, He H, et al
    Depression and health outcomes: An umbrella review of systematic reviews and meta-analyses of observational studies.
    Transl Psychiatry. 2025;15:298.
    PubMed    
    Abstract available
    
    

75. CAMPOS VMS, Prudente TP, Leao LL, da Costa MS, et al
    Analyses of different prescriptions for health using artificial intelligence: a critical approach based on the international guidelines of health institutions.
    Health Inf Sci Syst. 2025;13:52.
    PubMed    
    Abstract available
    
    

76. WANG SR, Zhou J, Zhang JY, Li SF, et al
    A bibliometric analysis of global research status and trends in irritable bowel syndrome and gut microbiota metabolites.
    Front Microbiol. 2025;16:1559926.
    PubMed    
    Abstract available
    
    

77. DOWAIS R, Muhanna SIJ, Ghafar RJ, Alzaqh M, et al
    Expectations of the adult population of the Hashemite Kingdom of Jordan about irritable bowel syndrome.
    Medicine (Baltimore). 2025;104:e43964.
    PubMed    
    Abstract available
    
    

78. SAIDARA E, Barlow GM, Pimentel M
    The evolution of irritable bowel syndrome as a group of organic diseases: a narrative review.
    Expert Rev Gastroenterol Hepatol. 2025.
    PubMed    
    Abstract available
    
    

79. ZHAO M, Luo R, Shen Y, Zhang Y, et al
    Factors associated with symptom relief in patients with irritable bowel syndrome: a retrospective cohort study.
    Front Med (Lausanne). 2025;12:1643177.
    PubMed    
    Abstract available
    
    

80. ALSHEHRI WM, Elhady HM, Alharbi AA, Alshehri WA, et al
    Prevalence of Irritable Bowel Syndrome and Its Association With Anxiety Among Family Physicians in Primary Healthcare in Tabuk, Saudi Arabia.
    Cureus. 2025;17:e88138.
    PubMed    
    Abstract available
    
    

81. KHALID A, Mohajer-Bastami A, Khamise A, Pouwels S, et al
    Evaluating Psychological Interventions for Pain, Recovery, and Outcomes in Surgical and Medical Care.
    Cureus. 2025;17:e88097.
    PubMed    
    Abstract available
    
    

82. SHAH ND, Staudacher HM
    Cultural competence in the delivery of nutrition and symptom care in irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2025 Aug 13:S2468-1253(25)00236.
    PubMed    
    
    
    

83. YE J, Sun H, Zhang Q, He J, et al
    Microalgae-based Intestinal villi-targeting multistage biosystem for irritable bowel syndrome treatment.
    Nat Commun. 2025;16:7614.
    PubMed    
    Abstract available
    
    

84. GRAD R, Ebell MH
    Top 20 Research Studies of 2024 for Primary Care Physicians.
    Am Fam Physician. 2025;112:34-41.
    PubMed    
    Abstract available
    
    

85. GREER KB, Sultan S
    Irritable Bowel Syndrome.
    Ann Intern Med. 2025 Aug 12. doi: 10.7326/ANNALS-25-01965.
    PubMed    
    Abstract available
    
    

86. KHURANA R, Rakhra G
    Assessing the Impact of the Low-FODMAP Diet on IBS Management in Asian Countries: A Systematic Review and Meta-Analysis of Evidence.
    Dig Dis Sci. 2025 Jul 27. doi: 10.1007/s10620-025-09241.
    PubMed    
    Abstract available
    
    

87. LI L, Xu L, Wang L, Sun Y, et al
    Role of AQP1 in the Ameliorating Effect of Electroacupuncture in a Rodent Model of Visceral Hypersensitivity.
    Dig Dis Sci. 2025 Aug 5. doi: 10.1007/s10620-025-09269.
    PubMed    
    Abstract available
    
    

88. BUZENSKI J, Davenport S, Glinky A, Edwards PT, et al
    A Practical Guide to Behavioral Treatment for Children with Disorders of Gut-Brain Interaction.
    Gastroenterol Clin North Am. 2025;54:639-649.
    PubMed    
    Abstract available
    
    

89. DI LORENZO C
    Social Media and Children with Disorders of Gut-Brain Interaction.
    Gastroenterol Clin North Am. 2025;54:627-638.
    PubMed    
    Abstract available
    
    

90. COHEN A, Wheeler JC
    New Pharmacologic Treatments in Pediatric Neurogastroenterology.
    Gastroenterol Clin North Am. 2025;54:569-587.
    PubMed    
    Abstract available
    
    

91. ARSLAN E, Kiyak E
    The Effects of Progressive Muscle Relaxation Exercises on Symptom Severity and Quality of Life in Patients With Irritable Bowel Syndrome.
    Gastroenterol Nurs. 2025;48:271-279.
    PubMed    
    Abstract available
    
    

92. GAO J, Lee AA, Abtahi S, Turner JR, et al
    Low FODMAP diet improves colonic barrier function and mast cell activation in patients with IBS-D: A mechanistic trial.
    Gastroenterology. 2025 Jul 18:S0016-5085(25)05771.
    PubMed    
    Abstract available
    
    

93. JI TT, Yao YH, Liu L, Li HS, et al
    Masked hypertension in patients with irritable bowel syndrome: A direction worthy of in-depth study.
    Indian J Gastroenterol. 2025 Aug 9. doi: 10.1007/s12664-025-01863.
    PubMed    
    
    
    

94. MACKRILL K, Bass C, Petrie K
    Comparing illness perceptions in inflammatory bowel disease and irritable bowel syndrome.
    J Psychosom Res. 2025;196:112337.
    PubMed    
    Abstract available
    
    

95. CHEN Y, Zhou Y, Liu S, Zhang Q, et al
    Bidirectional Association of Rheumatoid Arthritis and Irritable Bowel Syndrome: A Large-Scale Prospective Cohort Study.
    Mayo Clin Proc. 2025 Aug 2:S0025-6196(25)00282.
    PubMed    
    Abstract available
    
    

96. CAMILLERI M, Dellon ES
    Year in Review: Selection of Best Papers in Gastroenterology and Hepatology 2024.
    Mayo Clin Proc. 2025 Aug 1:S0025-6196(25)00310.
    PubMed    
    Abstract available
    
    

97. MADVA EN, Varma S, Small V, Dekel M, et al
    Pharmacologic neuromodulation for bloating.
    Scand J Gastroenterol. 2025 Aug 8:1-5. doi: 10.1080/00365521.2025.2544306.
    PubMed    
    Abstract available